These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1093 related articles for article (PubMed ID: 9007119)
21. A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer. Shea T; Graham M; Bernard S; Steagall A; Wiley J; Serody J; Brecher M; Bentley S; Johnston C; Vaisman A Semin Oncol; 1995 Oct; 22(5 Suppl 12):80-5. PubMed ID: 7481867 [TBL] [Abstract][Full Text] [Related]
22. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial. Greco FA; Hainsworth JD Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113 [TBL] [Abstract][Full Text] [Related]
23. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029 [TBL] [Abstract][Full Text] [Related]
24. Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer. Belani CP; Aisner J; Hiponia D; Engstrom C Semin Oncol; 1995 Aug; 22(4 Suppl 9):7-12. PubMed ID: 7544028 [TBL] [Abstract][Full Text] [Related]
25. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results. Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study. Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219 [TBL] [Abstract][Full Text] [Related]
27. A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer. Neill HB; Miller AA; Clamon GH; Perry MC; Crawford J; Green MR Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-130-S12-134. PubMed ID: 9331137 [TBL] [Abstract][Full Text] [Related]
28. Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: a European Cancer Centre effort. Giaccone G; Huizing M; ten Bokkel Huinink W; Koolen M; Postmus P; van Kralingen K; van Zandwijk N; Vermorken J; Beijnen J; Dalesio O Semin Oncol; 1994 Oct; 21(5 Suppl 8):34-8. PubMed ID: 7939761 [TBL] [Abstract][Full Text] [Related]
29. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial. Meerpohl HG; du Bois A; Luck HJ; Kühnle H; Möbus V; Kreienberg R; Bauknecht T; Köchli O; Bochtler H; Diergarten K Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-17-S2-22. PubMed ID: 9045330 [TBL] [Abstract][Full Text] [Related]
30. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer. von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121 [TBL] [Abstract][Full Text] [Related]